Article Text

Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Successful management of fulminant influenza A subtype H1N1 myocarditis
  1. Miguel Cobas1,
  2. Lilian Abbo2,
  3. Miguel Santos1,
  4. Clara Baccini-Jauregui2,
  5. Si Pham3
  1. 1Department of Anesthesiology, University of Miami, Miami, Florida, USA
  2. 2Department of Infectious Diseases, University of Miami, Miami, Florida, USA
  3. 3Department of Surgery, University of Miami, Miami, Florida, USA
  1. Correspondence to Miguel Cobas, cobas{at}miami.edu

Summary

The outbreak and spread of the new influenza A subtype H1N1 reached pandemic levels during 2009, with greater numbers of cases reported daily and numerous complications described. The present report concerns an atypical manifestation of the disease in a previously healthy middle-aged patient who presented with severe, refractory cardiogenic shock 4 days after being diagnosed as having influenza A. The patient was considered for emergency heart transplant. Successful treatment involved the use of a left ventricular assist device, extracorporeal membrane oxygenation, intravenous immunoglobulin and peramivir as therapeutics and bridging therapies for transplant. This case is a report of H1N1 fulminant myocarditis and illustrates the usefulness of a multidisciplinary approach in the care of these patients.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Not Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.